AT199392T

Multivalent and multispecific binding proteins, their manufacture and use.

Abstract

(57) Although it consisted of the 1st domain that consists of a coupling field of a summary immunoglobulin heavy chain variable domain, and the 2nd domain that consists of a coupling field of an immunoglobulin light chain variable domain and the above-mentioned domain is chained, The polypeptide which cannot unite mutually and cannot form an antigen binding site unites, and forms the antigen unity multimer which is 多 value or can have multiplex singularity, for example, a dimer. A domain can be chained by the linker of short peptide, or can be joined together directly. The double singularity dimer can have a longer linker. Those displays on the surface of the bacteriophage for easy selection of the method of producing polypeptides, those multimers, and a repertory and the binder in question and much practicality are indicated.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

73 members in 15 offices

This recordMember, by publication datePriority claim5 more offices are in the list below

Priority claims5

Priority claims
DocumentOfficeKindDate
9225453United KingdomA
9300816United KingdomA
93303614European Patent Office (EPO)A
9319969United KingdomA
9302492United KingdomW

Members73

Family members, oldest first
DocumentOfficeKind
GB9225453D0United KingdomD0
DK13093D0DenmarkD0
DK13993D0DenmarkD0
GB9300816D0United KingdomD0
GB9319969D0United KingdomD0
CA2150262A1CanadaA1
WO9413804A1World Intellectual Property Organization (WIPO)A1
AU5654894AAustraliaA
GB9412147D0United KingdomD0
GB9412166D0United KingdomD0
CA2155335A1CanadaA1
WO9418227A2World Intellectual Property Organization (WIPO)A2
AU6038094AAustraliaA
WO9418227A3World Intellectual Property Organization (WIPO)A3
CA2169620A1CanadaA1
WO9508577A1World Intellectual Property Organization (WIPO)A1
AU7621494AAustraliaA
CA2177367A1CanadaA1
WO9515388A1World Intellectual Property Organization (WIPO)A1
AU1117095AAustraliaA
NO952989D0NorwayD0
FI953705AFinlandA
EP0672142A1European Patent Office (EPO)A1
NO952989LNorwayL
EP0686162A1European Patent Office (EPO)A1
KR960701083ARepublic of KoreaA
JPH08504100AJapanA
JPH08506243AJapanA
EP0720624A1European Patent Office (EPO)A1
EP0731842A1European Patent Office (EPO)A1
AU674568B2AustraliaB2
NZ261571ANew ZealandA
JPH09503759AJapanA
JPH09506508AJapanA
AU680685B2AustraliaB2
US5739281AUnited States of AmericaA
AU690171B2AustraliaB2
AU690528B2AustraliaB2
US5837242AUnited States of AmericaA
EP0720624B1European Patent Office (EPO)B1
AT173740TAustriaT
ATE173740T1AustriaT1
DE69414870D1GermanyD1
ES2126145T3SpainT3
DE69414870T2GermanyT2
US5917018AUnited States of AmericaA
DK0720624T3DenmarkT3
US6010884AUnited States of AmericaA
EP0672142B1European Patent Office (EPO)B1
AT199392TThis recordAustriaT
ATE199392T1AustriaT1
DE69329974D1GermanyD1
CA2155335CCanadaC
ES2156149T3SpainT3
DK0672142T3DenmarkT3
DE69329974T2GermanyT2
KR100310739B1Republic of KoreaB1
US6492123B1United States of AmericaB1
EP0686162B1European Patent Office (EPO)B1
AT241642TAustriaT
ATE241642T1AustriaT1
DE69432744D1GermanyD1
US6589527B1United States of AmericaB1
DK0686162T3DenmarkT3
NO316274B1NorwayB1
ES2199959T3SpainT3
DE69432744T2GermanyT2
US2004058400A1United States of AmericaA1
FI113272BFinlandB
JP3695467B2JapanB2
JP3720353B2JapanB2
US7122646B2United States of AmericaB2
CA2150262CCanadaC